Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ruijgrok C, Dekker JM, Beulens JW, Brouwer IA, Coupe VMH, Heymans MW, et al. Size and shape of the associations of glucose, HbA1c, insulin and HOMA-IR with incident type 2 diabetes: the Hoorn Study. Diabetologia. 2018;61(1):93–100.

Article  PubMed  CAS  Google Scholar 

Kurl S, Zaccardi F, Onaemo VN, Jae SY, Kauhanen J, Ronkainen K, et al. Association between HOMA-IR, fasting insulin and fasting glucose with coronary heart disease mortality in nondiabetic men: a 20-year observational study. Acta Diabetol. 2015;52(1):183–6.

Article  PubMed  CAS  Google Scholar 

Meigs JB, Porneala B, Leong A, Shiffman D, Devlin JJ, McPhaul MJ. Simultaneous consideration of HbA1c and insulin resistance improves Risk Assessment in White individuals at increased risk for future type 2 diabetes. Diabetes Care. 2020;43(8):e90–2.

Article  PubMed  PubMed Central  Google Scholar 

Patel N, Taveira TH, Choudhary G, Whitlatch H, Wu WC. Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults. J Am Heart Assoc. 2012;1(6):e003152.

Article  PubMed  PubMed Central  Google Scholar 

Sokooti S, Kieneker LM, Borst MH, Muller Kobold A, Kootstra-Ros JE, Gloerich J et al. Plasma C-Peptide and risk of developing type 2 diabetes in the General Population. J Clin Med. 2020;9(9).

Leighton E, Sainsbury CA, Jones GC. A practical review of C-Peptide testing in diabetes. Diabetes Ther. 2017;8(3):475–87.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Abbasi F, Shiffman D, Tong CH, Devlin JJ, McPhaul MJ. Insulin resistance probability scores for apparently healthy individuals. J Endocr Soc. 2018;2(9):1050–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sarwar N, Sattar N, Gudnason V, Danesh J. Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 western prospective studies. Eur Heart J. 2007;28(20):2491–7.

Article  PubMed  Google Scholar 

Louie JZ, Shiffman D, McPhaul MJ, Melander O. Insulin resistance probability score and incident cardiovascular disease. J Intern Med. 2023;294(4):531–5.

Article  PubMed  CAS  Google Scholar 

Wahab N, Chen R, Curb JD, Willcox BJ, Rodriguez BL. The Association of Fasting Glucose, insulin, and C-Peptide, with 19-Year incidence of Coronary Heart Disease in older Japanese-American men; the Honolulu Heart Program. Geriatr (Basel). 2018;3(2).

Schmiegelow MD, Hedlin H, Stefanick ML, Mackey RH, Allison M, Martin LW, et al. Insulin resistance and risk of Cardiovascular Disease in Postmenopausal women: a Cohort Study from the women’s Health Initiative. Circ Cardiovasc Qual Outcomes. 2015;8(3):309–16.

Article  PubMed  Google Scholar 

Jahromi MK, Ahmadirad H, Jamshidi S, Farhadnejad H, Mokhtari E, Shahrokhtabar T, et al. The association of serum C-peptide with the risk of cardiovascular events: a meta-analysis and systematic review. Diabetol Metab Syndr. 2023;15(1):168.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brown TJ, Brainard J, Song F, Wang X, Abdelhamid A, Hooper L, et al. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. BMJ. 2019;366:l4697.

Article  PubMed  PubMed Central  Google Scholar 

Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016;133(2):187–225.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Del Gobbo LC, Imamura F, Aslibekyan S, Marklund M, Virtanen JK, Wennberg M, et al. omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies. JAMA Intern Med. 2016;176(8):1155–66.

Article  PubMed  PubMed Central  Google Scholar 

Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Marine n-3 fatty acids and Prevention of Cardiovascular Disease and Cancer. N Engl J Med. 2019;380(1):23–32.

Article  PubMed  CAS  Google Scholar 

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular Risk reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11–22.

Article  PubMed  CAS  Google Scholar 

Hu Y, Hu FB, Manson JE. Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants. J Am Heart Assoc. 2019;8(19):e013543.

Article  PubMed  PubMed Central  Google Scholar 

Gao H, Geng T, Huang T, Zhao Q. Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis. Lipids Health Dis. 2017;16(1):131.

Article  PubMed  PubMed Central  Google Scholar 

Li X, Liu Y, Zheng Y, Wang P, Zhang Y. The effect of vitamin D supplementation on Glycemic Control in type 2 diabetes patients: a systematic review and Meta-analysis. Nutrients. 2018;10(3).

Pramono A, Jocken JWE, Blaak EE, van Baak MA. The effect of vitamin D supplementation on insulin sensitivity: a systematic review and Meta-analysis. Diabetes Care. 2020;43(7):1659–69.

Article  PubMed  CAS  Google Scholar 

Lu L, Bennett DA, Millwood IY, Parish S, McCarthy MI, Mahajan A, et al. Association of vitamin D with risk of type 2 diabetes: a mendelian randomisation study in European and Chinese adults. PLoS Med. 2018;15(5):e1002566.

Article  PubMed  PubMed Central  Google Scholar 

Zhang R, Li B, Gao X, Tian R, Pan Y, Jiang Y, et al. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies. Am J Clin Nutr. 2017;105(4):810–9.

Article  PubMed  CAS  Google Scholar 

Zhang Y, Tan H, Tang J, Li J, Chong W, Hai Y, et al. Effects of vitamin D supplementation on Prevention of type 2 diabetes in patients with prediabetes: a systematic review and Meta-analysis. Diabetes Care. 2020;43(7):1650–8.

Article  PubMed  CAS  Google Scholar 

Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Dhillon H, Swaid B, et al. Vitamin D supplementation and Cardiovascular Disease risks in more than 83000 individuals in 21 randomized clinical trials: a Meta-analysis. JAMA Cardiol. 2019;4(8):765–76.

Article  PubMed  PubMed Central  Google Scholar 

Taylor SW, Clarke NJ, Chen Z, McPhaul MJ. A high-throughput mass spectrometry assay to simultaneously measure intact insulin and C-peptide. Clin Chim Acta. 2016;455:202–8.

Article  PubMed  CAS  Google Scholar 

American Diabetes Association Professional, Practice C, American Diabetes Association Professional, Practice C, Draznin B, Aroda VR, Bakris G, Benson G, et al. 2. Classification and diagnosis of diabetes: standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–38.

Article  Google Scholar 

Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44.

Article  PubMed  CAS  Google Scholar 

Lawlor DA, Fraser A, Ebrahim S, Smith GD. Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women. PLoS Med. 2007;4(8):e263.

Article  PubMed  PubMed Central  Google Scholar 

Cabrera de Leon A, Oliva Garcia JG, Marcelino Rodriguez I, Almeida Gonzalez D, Aleman Sanchez JJ, Brito Diaz B, et al. C-peptide as a risk factor of coronary artery disease in the general population. Diab Vasc Dis Res. 2015;12(3):199–207.

Article  PubMed  CAS  Google Scholar 

Alves MT, Ortiz MMO, Dos Reis G, Dusse LMS, Carvalho MDG, Fernandes AP, et al. The dual effect of C-peptide on cellular activation and atherosclerosis: protective or not? Diabetes Metab Res Rev. 2019;35(1):e3071.

Article  PubMed  Google Scholar 

Goodarzi MO, Rotter JI. Genetics insights in the relationship between type 2 diabet